Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial Article Swipe
Neal D. Shore
,
Thomas Powles
,
Jens Bedke
,
Matthew D. Galsky
,
Joan Palou Redorta
,
Ja Hyeon Ku
,
Michal Kretkowski
,
Évanguelos Xylinas
,
B. Yа. Alekseev
,
Dingwei Ye
,
Félix Guerrero‐Ramos
,
Alberto Briganti
,
Girish S. Kulkarni
,
Julia Brinkmann
,
Anna Maria Calella
,
Rossano Cesari
,
Anthony Eccleston
,
Elisabete Michelon
,
Jennifer Vermette
,
Caimiao Wei
,
Gary D. Steinberg
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41591-025-03738-z
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41591-025-03738-z
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41591-025-03738-z
- https://www.nature.com/articles/s41591-025-03738-z.pdf
- OA Status
- hybrid
- Cited By
- 16
- References
- 26
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4410916531
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4410916531Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41591-025-03738-zDigital Object Identifier
- Title
-
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-05-31Full publication date if available
- Authors
-
Neal D. Shore, Thomas Powles, Jens Bedke, Matthew D. Galsky, Joan Palou Redorta, Ja Hyeon Ku, Michal Kretkowski, Évanguelos Xylinas, B. Yа. Alekseev, Dingwei Ye, Félix Guerrero‐Ramos, Alberto Briganti, Girish S. Kulkarni, Julia Brinkmann, Anna Maria Calella, Rossano Cesari, Anthony Eccleston, Elisabete Michelon, Jennifer Vermette, Caimiao Wei, Gary D. SteinbergList of authors in order
- Landing page
-
https://doi.org/10.1038/s41591-025-03738-zPublisher landing page
- PDF URL
-
https://www.nature.com/articles/s41591-025-03738-z.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41591-025-03738-z.pdfDirect OA link when available
- Concepts
-
Bladder cancer, Medicine, Crest, Randomized controlled trial, Cancer, Urothelial cancer, Oncology, Internal medicine, Urology, Physics, Quantum mechanicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
16Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 16Per-year citation counts (last 5 years)
- References (count)
-
26Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4410916531 |
|---|---|
| doi | https://doi.org/10.1038/s41591-025-03738-z |
| ids.doi | https://doi.org/10.1038/s41591-025-03738-z |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40450141 |
| ids.openalex | https://openalex.org/W4410916531 |
| fwci | 105.94210039 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D001749 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Urinary Bladder Neoplasms |
| mesh[2].qualifier_ui | Q000473 |
| mesh[2].descriptor_ui | D001749 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | pathology |
| mesh[2].descriptor_name | Urinary Bladder Neoplasms |
| mesh[3].qualifier_ui | Q000008 |
| mesh[3].descriptor_ui | D001500 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | administration & dosage |
| mesh[3].descriptor_name | BCG Vaccine |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D001500 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | BCG Vaccine |
| mesh[5].qualifier_ui | Q000009 |
| mesh[5].descriptor_ui | D001500 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | adverse effects |
| mesh[5].descriptor_name | BCG Vaccine |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008297 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Male |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000368 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Aged |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008875 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Middle Aged |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000369 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Aged, 80 and over |
| mesh[11].qualifier_ui | Q000008 |
| mesh[11].descriptor_ui | D061067 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | administration & dosage |
| mesh[11].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[12].qualifier_ui | Q000009 |
| mesh[12].descriptor_ui | D061067 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | adverse effects |
| mesh[12].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D061067 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D009361 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Neoplasm Invasiveness |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000328 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Adult |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D000971 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[17].qualifier_ui | Q000009 |
| mesh[17].descriptor_ui | D000971 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | adverse effects |
| mesh[17].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000093284 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Non-Muscle Invasive Bladder Neoplasms |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D001749 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Urinary Bladder Neoplasms |
| mesh[21].qualifier_ui | Q000473 |
| mesh[21].descriptor_ui | D001749 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | pathology |
| mesh[21].descriptor_name | Urinary Bladder Neoplasms |
| mesh[22].qualifier_ui | Q000008 |
| mesh[22].descriptor_ui | D001500 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | administration & dosage |
| mesh[22].descriptor_name | BCG Vaccine |
| mesh[23].qualifier_ui | Q000627 |
| mesh[23].descriptor_ui | D001500 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | therapeutic use |
| mesh[23].descriptor_name | BCG Vaccine |
| mesh[24].qualifier_ui | Q000009 |
| mesh[24].descriptor_ui | D001500 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | adverse effects |
| mesh[24].descriptor_name | BCG Vaccine |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D008297 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Male |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D005260 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Female |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000368 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Aged |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D008875 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Middle Aged |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000369 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Aged, 80 and over |
| mesh[30].qualifier_ui | Q000008 |
| mesh[30].descriptor_ui | D061067 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | administration & dosage |
| mesh[30].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[31].qualifier_ui | Q000009 |
| mesh[31].descriptor_ui | D061067 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | adverse effects |
| mesh[31].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D061067 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D009361 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Neoplasm Invasiveness |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000328 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Adult |
| mesh[35].qualifier_ui | Q000627 |
| mesh[35].descriptor_ui | D000971 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | therapeutic use |
| mesh[35].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[36].qualifier_ui | Q000009 |
| mesh[36].descriptor_ui | D000971 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | adverse effects |
| mesh[36].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D000093284 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Non-Muscle Invasive Bladder Neoplasms |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D006801 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Humans |
| mesh[39].qualifier_ui | Q000188 |
| mesh[39].descriptor_ui | D001749 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | drug therapy |
| mesh[39].descriptor_name | Urinary Bladder Neoplasms |
| mesh[40].qualifier_ui | Q000473 |
| mesh[40].descriptor_ui | D001749 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | pathology |
| mesh[40].descriptor_name | Urinary Bladder Neoplasms |
| mesh[41].qualifier_ui | Q000008 |
| mesh[41].descriptor_ui | D001500 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | administration & dosage |
| mesh[41].descriptor_name | BCG Vaccine |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D001500 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | BCG Vaccine |
| mesh[43].qualifier_ui | Q000009 |
| mesh[43].descriptor_ui | D001500 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | adverse effects |
| mesh[43].descriptor_name | BCG Vaccine |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D008297 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Male |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D005260 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Female |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D000368 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Aged |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D008875 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Middle Aged |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D000369 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Aged, 80 and over |
| mesh[49].qualifier_ui | Q000008 |
| mesh[49].descriptor_ui | D061067 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | administration & dosage |
| mesh[49].descriptor_name | Antibodies, Monoclonal, Humanized |
| type | article |
| title | Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial |
| biblio.issue | 8 |
| biblio.volume | 31 |
| biblio.last_page | 2814 |
| biblio.first_page | 2806 |
| topics[0].id | https://openalex.org/T10458 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2746 |
| topics[0].subfield.display_name | Surgery |
| topics[0].display_name | Bladder and Urothelial Cancer Treatments |
| topics[1].id | https://openalex.org/T12695 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9886000156402588 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Urinary and Genital Oncology Studies |
| topics[2].id | https://openalex.org/T10269 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9864000082015991 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Epigenetics and DNA Methylation |
| is_xpac | False |
| apc_list.value | 9750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 11690 |
| apc_paid.value | 9750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 11690 |
| concepts[0].id | https://openalex.org/C2780352672 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7153070569038391 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q504775 |
| concepts[0].display_name | Bladder cancer |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6535824537277222 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C48880136 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5884162187576294 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q864673 |
| concepts[2].display_name | Crest |
| concepts[3].id | https://openalex.org/C168563851 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5439285635948181 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[3].display_name | Randomized controlled trial |
| concepts[4].id | https://openalex.org/C121608353 |
| concepts[4].level | 2 |
| concepts[4].score | 0.48577550053596497 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[4].display_name | Cancer |
| concepts[5].id | https://openalex.org/C3020745361 |
| concepts[5].level | 4 |
| concepts[5].score | 0.47332462668418884 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2501186 |
| concepts[5].display_name | Urothelial cancer |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4115757346153259 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4095233380794525 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C126894567 |
| concepts[8].level | 1 |
| concepts[8].score | 0.36900150775909424 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q105650 |
| concepts[8].display_name | Urology |
| concepts[9].id | https://openalex.org/C121332964 |
| concepts[9].level | 0 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[9].display_name | Physics |
| concepts[10].id | https://openalex.org/C62520636 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q944 |
| concepts[10].display_name | Quantum mechanics |
| keywords[0].id | https://openalex.org/keywords/bladder-cancer |
| keywords[0].score | 0.7153070569038391 |
| keywords[0].display_name | Bladder cancer |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6535824537277222 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/crest |
| keywords[2].score | 0.5884162187576294 |
| keywords[2].display_name | Crest |
| keywords[3].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[3].score | 0.5439285635948181 |
| keywords[3].display_name | Randomized controlled trial |
| keywords[4].id | https://openalex.org/keywords/cancer |
| keywords[4].score | 0.48577550053596497 |
| keywords[4].display_name | Cancer |
| keywords[5].id | https://openalex.org/keywords/urothelial-cancer |
| keywords[5].score | 0.47332462668418884 |
| keywords[5].display_name | Urothelial cancer |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.4115757346153259 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.4095233380794525 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/urology |
| keywords[8].score | 0.36900150775909424 |
| keywords[8].display_name | Urology |
| language | en |
| locations[0].id | doi:10.1038/s41591-025-03738-z |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S203256638 |
| locations[0].source.issn | 1078-8956, 1546-170X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1078-8956 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nature Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://www.nature.com/articles/s41591-025-03738-z.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nature Medicine |
| locations[0].landing_page_url | https://doi.org/10.1038/s41591-025-03738-z |
| locations[1].id | pmid:40450141 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Nature medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40450141 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12353837 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Nat Med |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12353837 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5088518998 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5767-0548 |
| authorships[0].author.display_name | Neal D. Shore |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210165013 |
| authorships[0].affiliations[0].raw_affiliation_string | START Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC, USA. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I4210165013 |
| authorships[0].institutions[0].ror | https://ror.org/05vk9vy20 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210165013 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Carolina Urologic Research Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Neal D Shore |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | START Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC, USA. [email protected]. |
| authorships[1].author.id | https://openalex.org/A5089861374 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-7760-4724 |
| authorships[1].author.display_name | Thomas Powles |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I166337079 |
| authorships[1].affiliations[0].raw_affiliation_string | Barts Health Biomedical NIHR Research Centre, Queen Mary University of London, London, UK. |
| authorships[1].institutions[0].id | https://openalex.org/I166337079 |
| authorships[1].institutions[0].ror | https://ror.org/026zzn846 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I166337079 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | Queen Mary University of London |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Thomas B Powles |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Barts Health Biomedical NIHR Research Centre, Queen Mary University of London, London, UK. |
| authorships[2].author.id | https://openalex.org/A5080116321 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2778-3108 |
| authorships[2].author.display_name | Jens Bedke |
| authorships[2].countries | DE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210161485 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Urology & Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany. |
| authorships[2].institutions[0].id | https://openalex.org/I4210161485 |
| authorships[2].institutions[0].ror | https://ror.org/059jfth35 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210161485 |
| authorships[2].institutions[0].country_code | DE |
| authorships[2].institutions[0].display_name | Klinikum Stuttgart |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jens Bedke |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Urology & Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany. |
| authorships[3].author.id | https://openalex.org/A5018275141 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7655-9378 |
| authorships[3].author.display_name | Matthew D. Galsky |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210127401 |
| authorships[3].affiliations[0].raw_affiliation_string | The Tisch Cancer Institute, Mount Sinai, New York, NY, USA. |
| authorships[3].institutions[0].id | https://openalex.org/I4210127401 |
| authorships[3].institutions[0].ror | https://ror.org/02gkddr41 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210086933, https://openalex.org/I4210127401 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Tisch Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Matthew D Galsky |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | The Tisch Cancer Institute, Mount Sinai, New York, NY, USA. |
| authorships[4].author.id | https://openalex.org/A5077718510 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Joan Palou Redorta |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I123044942, https://openalex.org/I4210143013 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain. |
| authorships[4].institutions[0].id | https://openalex.org/I4210143013 |
| authorships[4].institutions[0].ror | https://ror.org/03qwx2883 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210143013 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Puigvert Foundation |
| authorships[4].institutions[1].id | https://openalex.org/I123044942 |
| authorships[4].institutions[1].ror | https://ror.org/052g8jq94 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I123044942 |
| authorships[4].institutions[1].country_code | ES |
| authorships[4].institutions[1].display_name | Universitat Autònoma de Barcelona |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Joan Palou Redorta |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain. |
| authorships[5].author.id | https://openalex.org/A5016904761 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0391-2342 |
| authorships[5].author.display_name | Ja Hyeon Ku |
| authorships[5].countries | KR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2802835388 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea. |
| authorships[5].institutions[0].id | https://openalex.org/I2802835388 |
| authorships[5].institutions[0].ror | https://ror.org/01z4nnt86 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2802835388 |
| authorships[5].institutions[0].country_code | KR |
| authorships[5].institutions[0].display_name | Seoul National University Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ja Hyeon Ku |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea. |
| authorships[6].author.id | https://openalex.org/A5093693986 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Michal Kretkowski |
| authorships[6].affiliations[0].raw_affiliation_string | Clinical Research Center, Spolka z Ograniczona, Poznań, Poland. |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Michal Kretkowski |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Clinical Research Center, Spolka z Ograniczona, Poznań, Poland. |
| authorships[7].author.id | https://openalex.org/A5020529503 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-9440-4895 |
| authorships[7].author.display_name | Évanguelos Xylinas |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I100532134, https://openalex.org/I204730241, https://openalex.org/I4210097159, https://openalex.org/I4210145170 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris Cité, Paris, France. |
| authorships[7].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[7].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[7].institutions[1].id | https://openalex.org/I4210145170 |
| authorships[7].institutions[1].ror | https://ror.org/03fdnmv92 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210145170 |
| authorships[7].institutions[1].country_code | FR |
| authorships[7].institutions[1].display_name | Hôpital Bichat-Claude-Bernard |
| authorships[7].institutions[2].id | https://openalex.org/I100532134 |
| authorships[7].institutions[2].ror | https://ror.org/029brtt94 |
| authorships[7].institutions[2].type | education |
| authorships[7].institutions[2].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[7].institutions[2].country_code | FR |
| authorships[7].institutions[2].display_name | Université Claude Bernard Lyon 1 |
| authorships[7].institutions[3].id | https://openalex.org/I204730241 |
| authorships[7].institutions[3].ror | https://ror.org/05f82e368 |
| authorships[7].institutions[3].type | education |
| authorships[7].institutions[3].lineage | https://openalex.org/I204730241 |
| authorships[7].institutions[3].country_code | FR |
| authorships[7].institutions[3].display_name | Université Paris Cité |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Evanguelos Xylinas |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris Cité, Paris, France. |
| authorships[8].author.id | https://openalex.org/A5019977496 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-3398-4128 |
| authorships[8].author.display_name | B. Yа. Alekseev |
| authorships[8].countries | RU |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210139937 |
| authorships[8].affiliations[0].raw_affiliation_string | P. Hertsen Moscow Cancer Research Institute, Moscow, Russia. |
| authorships[8].institutions[0].id | https://openalex.org/I4210139937 |
| authorships[8].institutions[0].ror | https://ror.org/04rbazs75 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210117042, https://openalex.org/I4210139937 |
| authorships[8].institutions[0].country_code | RU |
| authorships[8].institutions[0].display_name | P.A. Hertzen Moscow Oncology Research Institute |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Boris Alekseev |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | P. Hertsen Moscow Cancer Research Institute, Moscow, Russia. |
| authorships[9].author.id | https://openalex.org/A5101763457 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4974-3780 |
| authorships[9].author.display_name | Dingwei Ye |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210093194 |
| authorships[9].affiliations[0].raw_affiliation_string | Fudan University Shanghai Cancer Center, Shanghai, China. |
| authorships[9].institutions[0].id | https://openalex.org/I4210093194 |
| authorships[9].institutions[0].ror | https://ror.org/00my25942 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210093194 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Fudan University Shanghai Cancer Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Dingwei Ye |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Fudan University Shanghai Cancer Center, Shanghai, China. |
| authorships[10].author.id | https://openalex.org/A5061349789 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0767-3465 |
| authorships[10].author.display_name | Félix Guerrero‐Ramos |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210101691 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain. |
| authorships[10].institutions[0].id | https://openalex.org/I4210101691 |
| authorships[10].institutions[0].ror | https://ror.org/00qyh5r35 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210101691, https://openalex.org/I4210139293 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Hospital Universitario 12 De Octubre |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Félix Guerrero-Ramos |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain. |
| authorships[11].author.id | https://openalex.org/A5031550729 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2178-0494 |
| authorships[11].author.display_name | Alberto Briganti |
| authorships[11].countries | IT |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I154387261, https://openalex.org/I4210153126, https://openalex.org/I4387155925 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. |
| authorships[11].institutions[0].id | https://openalex.org/I4387155925 |
| authorships[11].institutions[0].ror | https://ror.org/006x48140 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210153126, https://openalex.org/I4387155925 |
| authorships[11].institutions[0].country_code | |
| authorships[11].institutions[0].display_name | Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele |
| authorships[11].institutions[1].id | https://openalex.org/I4210153126 |
| authorships[11].institutions[1].ror | https://ror.org/04tfzc498 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210153126 |
| authorships[11].institutions[1].country_code | IT |
| authorships[11].institutions[1].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[11].institutions[2].id | https://openalex.org/I154387261 |
| authorships[11].institutions[2].ror | https://ror.org/01gmqr298 |
| authorships[11].institutions[2].type | education |
| authorships[11].institutions[2].lineage | https://openalex.org/I154387261 |
| authorships[11].institutions[2].country_code | IT |
| authorships[11].institutions[2].display_name | Vita-Salute San Raffaele University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Alberto Briganti |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. |
| authorships[12].author.id | https://openalex.org/A5018908850 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-6929-6124 |
| authorships[12].author.display_name | Girish S. Kulkarni |
| authorships[12].countries | CA |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[12].affiliations[0].raw_affiliation_string | Division of Urology, Department of Surgery, Princess Margaret Cancer, Center University of Toronto, Toronto, ON, Canada. |
| authorships[12].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[12].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[12].institutions[0].country_code | CA |
| authorships[12].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[12].institutions[1].id | https://openalex.org/I185261750 |
| authorships[12].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[12].institutions[1].country_code | CA |
| authorships[12].institutions[1].display_name | University of Toronto |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Girish S Kulkarni |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Division of Urology, Department of Surgery, Princess Margaret Cancer, Center University of Toronto, Toronto, ON, Canada. |
| authorships[13].author.id | https://openalex.org/A5081190896 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8064-0101 |
| authorships[13].author.display_name | Julia Brinkmann |
| authorships[13].countries | DE |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210100293 |
| authorships[13].affiliations[0].raw_affiliation_string | Pfizer Pharma GmbH, Berlin, Germany. |
| authorships[13].institutions[0].id | https://openalex.org/I4210100293 |
| authorships[13].institutions[0].ror | https://ror.org/00m8w3m39 |
| authorships[13].institutions[0].type | company |
| authorships[13].institutions[0].lineage | https://openalex.org/I180857899, https://openalex.org/I4210100293 |
| authorships[13].institutions[0].country_code | DE |
| authorships[13].institutions[0].display_name | Pfizer (Germany) |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Julia Brinkmann |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Pfizer Pharma GmbH, Berlin, Germany. |
| authorships[14].author.id | https://openalex.org/A5049676800 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Anna Maria Calella |
| authorships[14].countries | IT |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210142120 |
| authorships[14].affiliations[0].raw_affiliation_string | Pfizer SRL, Rome, Italy. |
| authorships[14].institutions[0].id | https://openalex.org/I4210142120 |
| authorships[14].institutions[0].ror | https://ror.org/03htt2d69 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I180857899, https://openalex.org/I4210142120 |
| authorships[14].institutions[0].country_code | IT |
| authorships[14].institutions[0].display_name | Pfizer (Italy) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Anna-Maria Calella |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Pfizer SRL, Rome, Italy. |
| authorships[15].author.id | https://openalex.org/A5026606309 |
| authorships[15].author.orcid | https://orcid.org/0009-0008-3757-3220 |
| authorships[15].author.display_name | Rossano Cesari |
| authorships[15].countries | IT |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210142120 |
| authorships[15].affiliations[0].raw_affiliation_string | Pfizer SRL, Milan, Italy. |
| authorships[15].institutions[0].id | https://openalex.org/I4210142120 |
| authorships[15].institutions[0].ror | https://ror.org/03htt2d69 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I180857899, https://openalex.org/I4210142120 |
| authorships[15].institutions[0].country_code | IT |
| authorships[15].institutions[0].display_name | Pfizer (Italy) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Rossano Cesari |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Pfizer SRL, Milan, Italy. |
| authorships[16].author.id | https://openalex.org/A5021623835 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Anthony Eccleston |
| authorships[16].countries | GB |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I189718659 |
| authorships[16].affiliations[0].raw_affiliation_string | Pfizer Ltd., Tadworth, UK. |
| authorships[16].institutions[0].id | https://openalex.org/I189718659 |
| authorships[16].institutions[0].ror | https://ror.org/04x4v8p40 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I180857899, https://openalex.org/I189718659 |
| authorships[16].institutions[0].country_code | GB |
| authorships[16].institutions[0].display_name | Pfizer (United Kingdom) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Anthony Eccleston |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Pfizer Ltd., Tadworth, UK. |
| authorships[17].author.id | https://openalex.org/A5005353528 |
| authorships[17].author.orcid | https://orcid.org/0009-0005-8362-3717 |
| authorships[17].author.display_name | Elisabete Michelon |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[17].affiliations[0].raw_affiliation_string | Pfizer Inc., New York, NY, USA. |
| authorships[17].institutions[0].id | https://openalex.org/I180857899 |
| authorships[17].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Pfizer (United States) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Elisabete Michelon |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Pfizer Inc., New York, NY, USA. |
| authorships[18].author.id | https://openalex.org/A5017512236 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Jennifer Vermette |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[18].affiliations[0].raw_affiliation_string | Pfizer Inc., Cambridge, MA, USA. |
| authorships[18].institutions[0].id | https://openalex.org/I180857899 |
| authorships[18].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Pfizer (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Jennifer Vermette |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Pfizer Inc., Cambridge, MA, USA. |
| authorships[19].author.id | https://openalex.org/A5110084144 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Caimiao Wei |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[19].affiliations[0].raw_affiliation_string | Pfizer Inc., Groton, CT, USA. |
| authorships[19].institutions[0].id | https://openalex.org/I180857899 |
| authorships[19].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Pfizer (United States) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Caimiao Wei |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Pfizer Inc., Groton, CT, USA. |
| authorships[20].author.id | https://openalex.org/A5055374861 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-4469-0624 |
| authorships[20].author.display_name | Gary D. Steinberg |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I1285301757 |
| authorships[20].affiliations[0].raw_affiliation_string | Department of Urology, Rush University Medical Center, Chicago, IL, USA. |
| authorships[20].institutions[0].id | https://openalex.org/I1285301757 |
| authorships[20].institutions[0].ror | https://ror.org/01j7c0b24 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I1285301757 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | Rush University Medical Center |
| authorships[20].author_position | last |
| authorships[20].raw_author_name | Gary D Steinberg |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Department of Urology, Rush University Medical Center, Chicago, IL, USA. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41591-025-03738-z.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10458 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2746 |
| primary_topic.subfield.display_name | Surgery |
| primary_topic.display_name | Bladder and Urothelial Cancer Treatments |
| related_works | https://openalex.org/W2386703018, https://openalex.org/W2072363325, https://openalex.org/W2609853501, https://openalex.org/W2045112790, https://openalex.org/W2379987890, https://openalex.org/W979452887, https://openalex.org/W4386034068, https://openalex.org/W134955408, https://openalex.org/W1540265934, https://openalex.org/W2355769538 |
| cited_by_count | 16 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 16 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1038/s41591-025-03738-z |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S203256638 |
| best_oa_location.source.issn | 1078-8956, 1546-170X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1078-8956 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nature Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41591-025-03738-z.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nature Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41591-025-03738-z |
| primary_location.id | doi:10.1038/s41591-025-03738-z |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S203256638 |
| primary_location.source.issn | 1078-8956, 1546-170X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1078-8956 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nature Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://www.nature.com/articles/s41591-025-03738-z.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nature Medicine |
| primary_location.landing_page_url | https://doi.org/10.1038/s41591-025-03738-z |
| publication_date | 2025-05-31 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2889646458, https://openalex.org/W4391169343, https://openalex.org/W4401664244, https://openalex.org/W4205103362, https://openalex.org/W3164781831, https://openalex.org/W2740718785, https://openalex.org/W2946902525, https://openalex.org/W3088493271, https://openalex.org/W2892779818, https://openalex.org/W4393356996, https://openalex.org/W2803928489, https://openalex.org/W4391251689, https://openalex.org/W1947168884, https://openalex.org/W2033433258, https://openalex.org/W4224512027, https://openalex.org/W3120806671, https://openalex.org/W1965580073, https://openalex.org/W2084204019, https://openalex.org/W4407599090, https://openalex.org/W4394679134, https://openalex.org/W3210474759, https://openalex.org/W4226360696, https://openalex.org/W3133795314, https://openalex.org/W4393166359, https://openalex.org/W4387329458, https://openalex.org/W4393935425 |
| referenced_works_count | 26 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| countries_distinct_count | 10 |
| institutions_distinct_count | 21 |
| citation_normalized_percentile.value | 0.99947096 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |